U.S. markets closed

Amdocs Limited (DOX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
77.90+2.28 (+3.02%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close75.62
Open76.44
Bid77.94 x 1300
Ask77.94 x 2200
Day's Range76.03 - 78.13
52 Week Range54.68 - 82.38
Volume722,588
Avg. Volume987,622
Market Cap10.191B
Beta (5Y Monthly)0.79
PE Ratio (TTM)15.30
EPS (TTM)5.09
Earnings DateAug 03, 2021 - Aug 09, 2021
Forward Dividend & Yield1.44 (1.90%)
Ex-Dividend DateMar 30, 2021
1y Target Est84.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-8% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amdocs Limited of Class Action Lawsuit and Upcoming Deadline – DOX

      NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Amdocs Limited (“Amdocs” or the “Company”) (NASDAQ: DOX), and certain of its officers. The class action, filed in the United States District Court for the Central District of California, and docketed under 21-cv-03078, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Amdocs ordinary shares between December 13, 2016 and March 30, 2021, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. If you are a shareholder who purchased Amdocs ordinary shares during the Class Period, you have until June 8, 2021 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action] Amdocs, through its global subsidiaries, provides software and services to communications, cable and satellite, entertainment, and media industry service providers worldwide. Historically, the Company’s largest percentage of revenues come from its North American business, mostly the U.S., particularly from large customers including, among others, AT&T Inc. (“AT&T”). The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Amdocs overstated its profits, cash, and liquidity, while understating its debt; (ii) Amdocs concealed its large borrowing; (iii) while Amdocs’ reported results showed that its North American business was stable, that business was actually deteriorating annually, in part because the Company was losing AT&T as a customer; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times. On March 31, 2021, pre-market, Jehoshaphat Research published a short-seller report addressing Amdocs, which alleged, inter alia, that Amdocs overstated its profits, evidenced by steady parent profits despite declining subsidiary profits; that there was a concerning pattern of reputable auditors resigning, only to be replaced by “scandal-plagued or tiny shops”; that Amdocs “window-dressed” its balance sheets to keep its large borrowing a secret, namely by paying down its debt just prior to the end of each quarter, therefore showing a debt-free balance sheet on that day, before re-borrowing the money shortly thereafter; and that all of the foregoing was corroborated by former employees and direct competitors of the Company, who noted that Amdocs was losing AT&T as a customer, as well as a former American Amdocs executive, who stated that the Company’s “US business was declining at a rate of [around] 7% annually . . . but then we would see the company [publish results that] say North America is stable.” On this news, Amdocs’ ordinary share price fell $9.19 per share, or 11.58%, to close at $70.15 per share on March 31, 2021. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com CONTACT:Robert S. WilloughbyPomerantz LLPrswilloughby@pomlaw.com888-476-6529 ext. 7980

    • SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DOX, FGEN, GOEV, VRM INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
      GlobeNewswire

      SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DOX, FGEN, GOEV, VRM INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

      NEW ORLEANS, May 14, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Vroom, Inc. (VRM)Class Period: 6/9/2020 - 3/3/2021Lead Plaintiff Motion Deadline: May 21, 2021SECURITIES FRAUDTo learn more, visit https://www.ksfcounsel.com/cases/nasdaqgs-vrm/ Canoo Inc. (GOEV, GOEVW)Class Period: 8/18/2020 - 3/29/2021Lead Plaintiff Motion Deadline: June 1, 2021SECURITIES FRAUDTo learn more, visit https://www.ksfcounsel.com/cases/nasdaqgs-goev/ Amdocs Limited (DOX)Class Period: 12/13/2016 - 3/30/2021Lead Plaintiff Motion Deadline: June 8, 2021SECURITIES FRAUDTo learn more, visit https://www.ksfcounsel.com/cases/nasdaqgs-dox/ FibroGen, Inc. (FGEN)Class Period: 10/18/2017 - 4/6/2021Lead Plaintiff Motion Deadline: June 11, 2021SECURITIES FRAUDTo learn more, visit https://www.ksfcounsel.com/cases/nasdaqgs-fgen/ If you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner, Lewis Kahn, toll-free at 1-877-515-1850, via email (Lewis.Kahn@KSFcounsel.com), or via the case links above. If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline. About KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana. To learn more about KSF, you may visit www.ksfcounsel.com. Contact: Kahn Swick & Foti, LLCLewis Kahn, Managing Partnerlewis.kahn@ksfcounsel.com1-877-515-18501100 Poydras St., Suite 3200New Orleans, LA 70163

    • SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amdocs Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 8, 2021 - DOX
      Newsfile

      SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amdocs Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 8, 2021 - DOX

      New York, New York--(Newsfile Corp. - May 14, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Amdocs Limited ("Amdocs") (NASDAQ: DOX) between December 13, 2016 and March 30, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Central District of California. To get more information ...